Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to $123000.0.

  • Guided Therapeutics' Prepaid Assets fell 4170.62% to $123000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $123000.0, marking a year-over-year decrease of 4170.62%. This contributed to the annual value of $173000.0 for FY2024, which is 613.5% up from last year.
  • Guided Therapeutics' Prepaid Assets amounted to $123000.0 in Q3 2025, which was down 4170.62% from $23000.0 recorded in Q2 2025.
  • In the past 5 years, Guided Therapeutics' Prepaid Assets registered a high of $453000.0 during Q1 2022, and its lowest value of $23000.0 during Q2 2025.
  • Its 5-year average for Prepaid Assets is $152315.8, with a median of $137000.0 in 2022.
  • Per our database at Business Quant, Guided Therapeutics' Prepaid Assets soared by 106153.85% in 2022 and then plummeted by 7946.43% in 2025.
  • Over the past 5 years, Guided Therapeutics' Prepaid Assets (Quarter) stood at $377000.0 in 2021, then plummeted by 63.66% to $137000.0 in 2022, then grew by 18.98% to $163000.0 in 2023, then rose by 6.13% to $173000.0 in 2024, then dropped by 28.9% to $123000.0 in 2025.
  • Its last three reported values are $123000.0 in Q3 2025, $23000.0 for Q2 2025, and $61000.0 during Q1 2025.